354
Participants
Start Date
March 4, 2021
Primary Completion Date
October 31, 2024
Study Completion Date
June 30, 2025
Control group
placebo 2 months treatment: 2 tablets during 4 weeks + 1 tablet during 4 weeks
ASA group
Acetylsalicylic acid 2 months treatment: 2 tablets during 4 weeks (600 mg daily) + 1 tablet during 4 weeks (300 mg daily)
IBU group
Ibuprofen 2 months treatment: 2 tablets during 4 weeks (800 mg daily) + 1 tablet during 4 weeks (400 mg daily)
SoC TB
Standard of Care Tuberculosis treatment
RECRUITING
Perinatal HIV Unit (PHRU)- Chris Hani Baragwanath Hospital, Soweto
RECRUITING
National Center for Tuberculosis and Lung Diseases, Tbilisi
RECRUITING
PHRU- Matlosana, Tshepong Hospital MDR Unit, Klerksdorp
National Center for Tuberculosis and Lung Disease, Tbilisi, Georgia
OTHER
Perinatal HIV Research Unit of the University of the Witswatersrand
OTHER
Fundació Institut Germans Trias i Pujol
OTHER